PERAN TABLET CURCUMA DALAM MENURUNKAN RISIKO HEPATOTOKSISITAS PADA PASIEN TB PARU YANG MENJALANI TERAPI OAT DI RS PASAR REBO KOTA JAKARTA TIMUR

Authors

  • Dini Permata Sari Fakultas Farmasi, Universitas 17 Agusuts 1945 Jakarta
  • Nhila Putri Evani
  • Rangki Astiani

DOI:

https://doi.org/10.51225/jps.v9i1.88

Keywords:

Curcuma, AST, ALT, Total Bilirubin, OAT, Pulmanary TB

Abstract

Abstract: Curcuma is known to play a role in preventing the side effects of anti-tuberculosis drugs (OAT), including hepatotoxicity, by protecting liver cells from oxidative stress and inflammation induced by drugs. The objective of this study was to determine the relationship between Curcuma tablet supplementation and the level of liver damage (hepatotoxicity), as measured by AST, ALT, and total bilirubin levels in pulmonary tuberculosis patients at Pasar Rebo Hospital. This study was non-experimental and classified as an analytical study with a cross-sectional approach. Data collection was conducted retrospectively, by reviewing past medical data and events. The sample in this study consisted of a portion of pulmonary tuberculosis patients undergoing OAT therapy at Pasar Rebo Hospital, East Jakarta, during the period of January–December 2024. The results showed that Curcuma tablet supplementation provided significant benefits to the liver health of pulmonary TB patients, as indicated by a statistically significant decrease in AST, ALT, and total bilirubin levels (p < 0.05) after treatment. This decrease in liver enzyme and bilirubin levels reflects improved hepatic function and reduced hepatotoxicity. Thus, Curcuma tablets have been proven effective as a hepatoprotective agent in the context of OAT therapy..

References

Basir, N., Djabir, Y.Y. and Santoso, A. (2021) ‘Case Reports on Severe Antituberculosis-Drug Induced Hepatotoxicity in Tuberculosis Patients: The Post-Incidence Therapy’, Nusantara Medical Science Journal, 5(1), pp. 44–50. Available at: https://doi.org/10.20956/nmsj.v5i1.13450.

BPS DKI Jakarta (2019) Profil Kesehatan Provinsi DKI Jakarta Tahun 2019. Jakarta.

Cao, J. et al. (2018) ‘First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform’, Biochemical and Biophysical Research Communications, 497(2), pp. 485–491. Available at: https://doi.org/10.1016/j.bbrc.2018.02.030.

Dalimartha (2004) Atlas Tumbuhan Obat Indonesia. 2nd edn. Jakarta: Puspa Swara.

Darliana, D. (2011) ‘Manajemen Pasien Tuberculosis Paru’, Idea Nursing Journal, 2(1).

Dehzad, M.J. et al. (2023) ‘Effects of curcumin/turmeric supplementation on liver function in adults: A GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials’, Complementary Therapies in Medicine, 74(May), p. 102952. Available at: https://doi.org/10.1016/j.ctim.2023.102952.

Djojodibroto, D. (2019) Respirologi (Respiratory Medicine). Jakarta: EGC.

Edwards, B.D. et al. (2023) ‘Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease’, Journal of the Association of Medical Microbiology and Infectious Disease Canada, 8(1), pp. 65–74. Available at: https://doi.org/10.3138/jammi-2022-0029.

Fahdhienie, F. et al. (2024) ‘Risk factors of pulmonary tuberculosis in Indonesia: A case-control study in a high disease prevalence region’, Narra J, 4(2), pp. 1–12. Available at: https://doi.org/http://doi.org/10.52225/narra.v4i2.943.

Fauzi, A.Z. et al. (2024) ‘Profil Penanda Fungsi Hati pada Pasien Tuberkulosis di Kota Kendari’, Molucca Medica, 17(2), pp. 124–130. Available at: https://doi.org/10.30598/molmed.2024.v17.i2.124.

Fortuna, T.A. et al. (2022) ‘Studi Penggunaan Obat Anti Tuberkulosis (OAT) Tahap Lanjutan pada Pasien Baru BTA Positif’, Pharmacon: Jurnal Farmasi Indonesia, 19(1), pp. 62–71. Available at: https://doi.org/10.23917/pharmacon.v19i1.17907.

Ghozali, I. (2021) Aplikasi Analisis Multivariete Dengan Program IBM SPSS 26. 10th edn. Semarang: Badan Penerbit Universitas Diponegoro.

Hidayat, A.A. (2013) Metode Penelitian Keperawatan dan Teknik Analisis Data. Jakarta: Salemba Medika.

Kemenkes RI (2018) ‘INFODATIN Tuberkulosis 2018’, Tuberkulosis, p. 2018. Available at: www.kemenkes.go.id.

KEMENKES RI (2019) Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis: Keputusan Menteri Kesehat Republik Indonesia Nomor HK0107/MENKES/755/2019. Indonesia.

KEMENKES RI (2024) Dashboard Tuberkulosis Indonesia. Indonesia.

Lai, N.H. et al. (2020) ‘Comparison of the predictive outcomes for anti-tuberculosis drug-induced hepatotoxicity by different machine learning techniques’, Computer Methods and Programs in Biomedicine, 188, p. 105307. Available at: https://doi.org/10.1016/j.cmpb.2019.105307.

Liu, Y. et al. (2023) ‘The effects of MDR-TB treatment regimens through socioeconomic and spatial characteristics on environmental-health outcomes: evidence from Chinese hospitals’, Energy & Environment, 34(4), pp. 1081–1093. Available at: https://doi.org/https://doi.org/10.1177/0958305X221079425.

Lubis, M.A. et al. (2025) ‘Hepatoprotective Activity of Ethanol Extract of Mobe Leaves (Artocarpus lacucha Buch-Ham.) on Total Bilirubin, ALT, and AST Levels, and Macropathology of Liver in Rats Induced by Carbon Tetrachloride’, Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan, 17(3), pp. 452–464. Available at: https://doi.org/10.35960/vm.v17i3.1490.

Mahayanti, N.K.S. and Sudarsana, I.P.A. (2022) ‘Laporan Kasus: Drug-induced liver injury pada pasien tuberkulosis relaps’, Intisari Sains Medis, 13(3), pp. 792–795. Available at: https://doi.org/10.15562/ism.v13i3.1554.

Mirlohi, M.-S. et al. (2016) ‘Hematological and liver toxicity of anti-tuberculosis drugs’, Electronic Physician, 8(9), pp. 3005–3010.

Molla, Y., Wubetu, M. and Dessie, B. (2021) ‘Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia’, Hepatic Medicine: Evidence and Research, 13, pp. 1–8. Available at: https://doi.org/10.2147/hmer.s290542.

Muttaqin, A. (2018) Buku Ajar Asuhan Keperawatan Klien dengan Gangguan Sistem Pernafasan. Jakarta: Salemba Medika.

Nadillah et al. (2022) ‘Hubungan Efek Samping Obat Anti Tuberkulosis (Oat) Terhadap Kepatuhan Minum Obat Pada Pasien Tb Paru Di Puskesmas’, Indonesian Journal of Nursing Health Science, 8(2), pp. 123–131. Available at: https://www.mendeley.com/catalogue/15c35e08-12a5-3771-8856-a55a0cae23f1/?utm_source=desktop&utm_medium=1.19.8&utm_campaign=open_catalog&userDocumentId=%7B9dda6999-a7d6-476e-908c-8e71fde69557%7D#abstract-title.

Nadiyah, Cahyani and Novianti, A. (2020) ‘Efektivitas Pemberian Tablet Curcuma, Putih Telur, dan Susu terhadap Asupan dan Berat Badan Pasien Tuberkulosis Dengan dan Tanpa Komorbiditas’, Nutrire Diaita, 12(02), pp. 52–59.

Naik, S.R., Thakare, V.N. and Patil, S.R. (2011) ‘Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: Evidence of its antioxidant property’, Experimental and Toxicologic Pathology, 63(5), pp. 419–431. Available at: https://doi.org/10.1016/j.etp.2010.03.001.

Napitupulu, R.R.J., Siregar, A.Y. and Ompusunggu, H.E.S. (2023) ‘Pengaruh Pemberian Ekstrak Daun Sirsak terhadap Kadar SGPT dan SGOT Tikus yang Di Induksi Obat Anti Tuberkulosis Isoniazid dan Rifampisin’, Nommensen Journal of Medicine, 9(1), pp. 6–9. Available at: https://doi.org/10.36655/njm.v9i1.1138.

Notoadmojo, S. (2018) Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.

Nursalam (2017) Metodologi penelitian ilmu keperawatan: Pendekatan Praktis. 4th edn. Jakarta: Salemba Medika.

Padila (2015) Buku Ajar Keperawatan Medikal Bedah. Yogyakarta: Nuha Medika.

Perwitasari, D.A. et al. (2022) ‘Investigating the Relationship between Knowledge and Hepatotoxic Effects with Medication Adherence of TB Patients in Banyumas Regency, Indonesia’, International Journal of Clinical Practice, 2022, pp. 1–6. Available at: https://doi.org/10.1155/2022/4044530.

Prakoso, H.H., Setiawan, A. and Sadewa, D. (2020) ‘Potensi Ekstrak Curcuma Xanthorrhiza Sebagai Terapi Pendamping Tuberkulosis’, Temu Ilmiah Nasional Program Studi Kedokteran, Fakultas Kedokteran, Universitas Sebelas Maret, Surakarta, pp. 1–7. Available at: https://doi.org/10.31219/osf.io/3z8kj.

Pramono, S. et al. (2018) ‘Hepatoprotective activity of curcuma xanthorrhiza Roxb. On paracetamol-induced liver damage in rats and correlation with their chemical compounds’, Thai Journal of Pharmaceutical Sciences, 42(4), pp. 188–195. Available at: https://doi.org/10.56808/3027-7922.2366.

Putri, M.S.P. (2013) ‘Si Kuning temulawak Curcuma xanthorrhiza Roxbdengan segudang khasiat’, Jurnal Teknologi Pangan, 2(2).

Rahmat, E., Lee, J. and Kang, Y. (2021) ‘Javanese Turmeric (Curcuma xanthorrhiza Roxb.): Ethnobotany, Phytochemistry, Biotechnology, and Pharmacological Activities’, Evidence-based Complementary and Alternative Medicine, pp. 1–15. Available at: https://doi.org/10.1155/2021/9960813.

Ruiz de Porras, V. et al. (2023) ‘Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury’, Life Sciences, 332, p. 122119. Available at: https://doi.org/https://doi.org/10.1016/j.lfs.2023.122119.

Sari, D.P. and Andriani, V. (2024) ‘Kajian Hubungan Penggunaan Obat Antituberkulosis Fase Awal terhadap Kadar SGOT-SGPT pada Pasien TBC Paru di RSUD Pasar Rebo di Jakarta’, Jurnal Kesehatan Tambusai, 5(4), pp. 10783–10792.

Setiawan, D. et al. (2024) ‘Peningkatan Daya Saing Menuju Masa Depan Desa Digital Pada Program Toga Sebagai Peningkatan Ekonomi di Desa Teluk Kenidai’, ARSY :Aplikasi Riset kepada Masyarakat, 5(2), pp. 231–237.

Siregar, S. et al. (2024) ‘Analysis of Liver Function and Hemoglobin Levels in Pulmonary Tuberculosis Patients with Anti-Tuberculosis Drugs’, Jurnal Kesehatan Manarang, 10(3), pp. 336–341.

Smeltzer, S.C. (2016) Keperawatan Medikal Bedah (Handbook for Brunner & Suddarth’s Textbook of Medical Surgical Nursing). 12th edn. Jakarta: EGC.

Soedarsono, S. et al. (2018) ‘the Risk Factors for Drug Induced Hepatitis in Pulmonary Tuberculosis Patients in Dr. Soetomo Hospital’, Indonesian Journal of Tropical and Infectious Disease, 7(3), p. 73. Available at: https://doi.org/10.20473/ijtid.v7i3.8689.

Soedarsono, S. and Riadi, A.R.W. (2020) ‘Tuberculosis Drug-Induced Liver Injury’, Jurnal Respirasi, 6(2), p. 49. Available at: https://doi.org/10.20473/jr.v6-i.2.2020.49-54.

Somantri, I. (2017) Keperawatan Medikal Bedah Asuhan Keperawatan pada Pasien dengan Gangguan Sistem Pernapasan. Jakarta: Salemba Medika.

Song, J.H. et al. (2019) ‘The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: A case control study’, Respiratory Research, 20(1), pp. 1–9. Available at: https://doi.org/10.1186/s12931-019-1256-y.

Sudoyo, A.W. et al. (2015) Buku Ajar Ilmu Penyakit Dalam. 4th edn. Jakarta: FK UI.

Sugiyono (2020) Metode Penelitian Kuantitatif, Kualitatif, dan R&D. Bandung: Alfabeta.

Sukumaran, D. et al. (2023) ‘A study to evaluate the hepatoprotective effect of N- acetylcysteine on anti tuberculosis drug induced hepatotoxicity and quality of life’, Indian Journal of Tuberculosis, 70(3), pp. 303–310. Available at: https://doi.org/https://doi.org/10.1016/j.ijtb.2022.05.012.

Sun, H. et al. (2025) ‘Role of Curcumin in Chronic Liver Diseases: A Comprehensive Review’, Drug Design, Development and Therapy, pp. 1–13. Available at: https://doi.org/10.2147/DDDT.S518547.

Syalia, T.P., Widada, N.S. and Ritonga, A.F. (2022) ‘Pemeriksaan Kadar Sgot-Sgpt Pada Lansia Penderita Tuberkulosis’, Binawan Student Journal, 4(1), pp. 9–13. Available at: https://doi.org/10.54771/bsj.v4i1.215.

Wahyudi, A.D. and Soedarsono, S. (2019) ‘Farmakogenomik Hepatotoksisitas Obat Anti Tuberkulosis’, Jurnal Respirasi, 1(3), p. 103. Available at: https://doi.org/10.20473/jr.v1-i.3.2015.103-108.

Wardhana, M.F., Milanda, T. and Sumiwi, S.A. (2018) ‘Assessment of Risk Factors of Hepatotoxicity among Tuberculosis Patients’, Pharmacology and Clinical Pharmacy Research, 3(1), pp. 10–15. Available at: https://doi.org/10.15416/pcpr.v3i1.16450.

WHO (2022) Tuberkulosis. Geneva.

Widoyono (2015) Penyakit Tropis : Epidemiologi, Penularan, Pencegahan, dan Pemberantasannya. Jakarta: Erlangga.

Yasni, S. et al. (1994) ‘Identification of an active principle in essential oils and hexane-soluble fractions of Curcuma xanthorrhiza Roxb. Showing triglyceride-lowering action in rats’, Food and Chemical Toxicology, 32(3), pp. 273–278.

Yudhasawra, N.A., Susilawati, N.M. and Udju, S.D. (2024) ‘Hubungan Lama Pengobatan Dengan Kadar Sgot Dan Sgpt Pada Pasien Tuberkulosis’, Journal of Nursing and Health, 9(3), pp. 299–306. Available at: https://doi.org/10.52488/jnh.v9i3.373.

Yustin, W.E.F. et al. (2022) ‘Prevalence and Onset of Hepatotoxicity Caused by Anti-Tuberculosis Drugs on Pulmonary TB Patients in Wangaya General Hospital Denpasar – Bali in 2016’, Health and Medical Journal, 4(3), pp. 153–159. Available at: https://doi.org/10.33854/heme.v4i3.998

Downloads

Published

2025-09-22

How to Cite

Dini Permata Sari, Nhila Putri Evani, & Rangki Astiani. (2025). PERAN TABLET CURCUMA DALAM MENURUNKAN RISIKO HEPATOTOKSISITAS PADA PASIEN TB PARU YANG MENJALANI TERAPI OAT DI RS PASAR REBO KOTA JAKARTA TIMUR. Journal Pharma Saintika, 9(1), 24–35. https://doi.org/10.51225/jps.v9i1.88